A study comparing peripheral blood, CSF, and post-mortem brain samples (divided into normal appearing white matter (NAWM) and lesions) of 27 MS patients identified lower levels of CD4+ T lymphocytes in comparison to CD8+ T lymphocytes in all sample groups. The gene discussed is CD8A; the disease is myeloid sarcoma.